CNY 16.18
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 81.2 Million | 125.96 Million | 187.24 Million | 148.24 Million | 59.75 Million | 35.02 Million |
Net Income | 79.23 Million | 166.72 Million | 106.78 Million | 74.65 Million | 107.54 Million | 73.27 Million |
Depreciation & Amortization | 53.92 Million | 44.88 Million | 45.29 Million | 36.8 Million | 30.08 Million | 13.32 Million |
Deferred income taxes | -10.57 Million | -6.45 Million | -2.78 Million | -864.42 Thousand | -3.88 Million | -2.15 Million |
Stock-based compensation | 1.35 Million | 3.11 Million | 945.51 Thousand | 601.29 Thousand | 3.89 Million | 6.48 Million |
Change in working capital | -111.61 Million | -112.26 Million | 20.76 Million | 17.7 Million | -89.83 Million | -55.26 Million |
Other non-cash items | 288.63 Million | 29.96 Million | 16.23 Million | 19.34 Million | 11.93 Million | 3.68 Million |
Investing Cash Flow | -135.15 Million | -160.02 Million | -241.04 Million | -285.03 Million | -130.99 Million | -74.74 Million |
Investments in PPE | -94.29 Million | -134.28 Million | -103.07 Million | -249.68 Million | -109.49 Million | -108.08 Million |
Acquisitions | 188.48 Thousand | 9.32 Million | 3.2 Million | 249.69 Million | -19.49 Million | -27.98 Million |
Investment purchases | -182 Million | -610.4 Million | -313.55 Million | -165.94 Million | -2 Million | -115 Million |
Sales/Maturities of investments | 140.95 Million | 584.62 Million | 175.57 Million | 130.57 Million | 109.49 Million | 176.31 Million |
Other Investing Activities | -40.44 Million | -9.28 Million | -3.19 Million | -249.68 Million | -109.49 Million | 1338.15 |
Financing Cash Flow | 55.05 Million | -14.24 Million | 99.9 Million | 159.11 Million | 66.74 Million | 39.35 Million |
Debt repayment | -91.71 Million | -234.07 Million | -340.24 Million | -339.78 Million | -119.48 Million | -5.38 Million |
Dividends payments | -30.25 Million | -21.59 Million | -19.25 Million | -18.99 Million | -20.35 Million | -21.15 Million |
Common Stock Repurchased | - | - | - | -70.88 Thousand | - | - |
Common Stock Issuance | - | - | - | 70.88 Thousand | - | - |
Other Financing Activities | -6.4 Million | 249.44 Million | 469.46 Million | 527.02 Million | 213.25 Million | 65.89 Million |
Accounts receivables | 1.95 Million | -54.66 Million | 23.29 Million | 10.87 Million | -20.07 Million | -52.29 Million |
Accounts payables | -48.64 Million | 84.21 Million | -3.99 Million | -19.08 Million | -10.48 Million | 35.59 Million |
Inventory | -63.85 Million | -135.36 Million | 4.25 Million | 26.78 Million | -55.39 Million | -36.41 Million |
Other working capital | -1.07 Million | -6.45 Million | -2.78 Million | -864.43 Thousand | -3.88 Million | -18.84 Million |
Cash at beginning of period | 72.68 Million | 109.57 Million | 63.32 Million | 41.31 Million | 46.42 Million | 46.06 Million |
Cash at end of period | 64.37 Million | 61.49 Million | 109.57 Million | 63.32 Million | 41.31 Million | 46.42 Million |
Capital Expenditure | -94.29 Million | -134.28 Million | -103.07 Million | -249.68 Million | -109.49 Million | -108.08 Million |
Effect of forex changes on cash | -418.33 Thousand | 226.09 Thousand | 151.81 Thousand | -319.78 Thousand | -614.03 Thousand | 729.03 Thousand |
Net cash flow / Change in cash | -8.3 Million | -48.07 Million | 46.25 Million | 22 Million | -5.1 Million | 361.88 Thousand |
Free Cash Flow | -13.09 Million | -8.31 Million | 84.16 Million | -101.43 Million | -49.73 Million | -73.05 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 14.15 Million | 43.48 Million | 19.28 Million | -2.71 Million | 79.23 Million | 2.54 Million |
Depreciation & Amortization | - | 15.44 Million | - | 14.04 Million | 53.92 Million | -25.47 Million |
Deferred income taxes | - | - | - | - | -10.57 Million | -81.48 Million |
Stock-based compensation | - | 518.69 Thousand | - | 1.35 Million | 1.35 Million | -2.23 Million |
Change in working capital | - | 139.69 Million | - | -62.97 Million | -111.61 Million | 109.11 Million |
Other non-cash items | 16.78 Million | -73.59 Million | -4.37 Million | 77.23 Million | 288.63 Million | 2.62 Million |
Investing Cash Flow | -7.25 Million | -27.74 Million | -31.86 Million | 17.04 Million | -135.15 Million | -89.34 Million |
Investments in PPE | -18.25 Million | -13.7 Million | -20.36 Million | -21.98 Million | -94.29 Million | -22.91 Million |
Acquisitions | 800.00 | 282.76 Thousand | 21.62 Thousand | 152.09 Thousand | 188.48 Thousand | 0.55 |
Investment purchases | -16.5 Million | -52.34 Million | -18.72 Million | -24.07 Million | -182 Million | -49 Million |
Sales/Maturities of investments | 37 Million | 38.02 Million | 7.2 Million | 35.45 Million | 140.95 Million | 10.07 Million |
Other Investing Activities | -9.5 Million | -13.91 Million | -11.49 Million | 27.5 Million | -40.44 Million | -27.5 Million |
Financing Cash Flow | -25.54 Million | 62.79 Million | 43.28 Million | -69.7 Million | 55.05 Million | 68.92 Million |
Debt repayment | -11 Million | -49.52 Million | -60.28 Million | -54.4 Million | -91.71 Million | -62.71 Million |
Dividends payments | - | -1.98 Million | -1.88 Million | -30.25 Million | -30.25 Million | -23.88 Million |
Common Stock Repurchased | 2.91 Million | -2.91 Million | - | - | - | 185.22 Thousand |
Common Stock Issuance | - | - | - | - | - | -185.22 Thousand |
Other Financing Activities | -17.44 Million | 16.17 Million | -16.99 Million | 14.95 Million | -6.4 Million | 155.52 Million |
Accounts receivables | - | 163.08 Million | - | 1.95 Million | 1.95 Million | 129.63 Million |
Accounts payables | - | - | - | - | -48.64 Million | - |
Inventory | - | -23.39 Million | - | -63.85 Million | -63.85 Million | -20.51 Million |
Other working capital | - | - | - | -1.07 Million | -1.07 Million | - |
Cash at beginning of period | 76.08 Million | 101.71 Million | 64.37 Million | 58.44 Million | 72.68 Million | 69.9 Million |
Cash at end of period | 74.56 Million | 76.08 Million | 101.71 Million | 64.37 Million | 64.37 Million | 54.72 Million |
Capital Expenditure | -18.25 Million | -13.7 Million | -20.36 Million | -21.98 Million | -94.29 Million | -22.91 Million |
Effect of forex changes on cash | - | -2.23 Million | -690.82 Thousand | -369.49 Thousand | -418.33 Thousand | 142.02 Thousand |
Net cash flow / Change in cash | -1.52 Million | -25.62 Million | 37.34 Million | 5.92 Million | -8.3 Million | -15.18 Million |
Free Cash Flow | 12.68 Million | -59.25 Million | -5.45 Million | 38.49 Million | -13.09 Million | -17.82 Million |
8150
KREBSBIO
VRSRF
TRG
218A
600282